Camilla Soenderby
Director/Board Member at BB BIOTECH AG
Network origin in Camilla Soenderby first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
15
| Public Company | Pharmaceuticals: Other | 15 |
| Public Company | Pharmaceuticals: Major | 13 | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.
12
| Holding Company | Pharmaceuticals: Major | 12 |
| Public Company | Financial Conglomerates | 10 | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Camilla Soenderby via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Comptroller/Controller/Auditor | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Human Resources Officer | |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Founder Founder Director/Board Member Chief Executive Officer | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| BELLEVUE GROUP AG | Investment Managers | Director of Finance/CFO Chairman Public Communications Contact | |
Bellevue Asset Management AG
 Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Investment Managers | Head-Equity Investments Portfolio Manager-Equities Chairman | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Sales & Marketing | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing Comptroller/Controller/Auditor | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Bocconi | College/University | Undergraduate Degree Undergraduate Degree | |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Biotechnology | Founder Director/Board Member | |
| Oncopeptides Incentive AB | Corporate Officer/Principal Director/Board Member | ||
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member Director/Board Member | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Chairman Chief Executive Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| GALENICA AG | Medical Distributors | Director/Board Member Director/Board Member | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| PHARNEXT SCA | Biotechnology | Founder Director/Board Member | |
| University of Birmingham | College/University | Doctorate Degree Doctorate Degree | |
| VERNALIS | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Consultant / Advisor Corporate Officer/Principal | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Administrative Officer Corporate Officer/Principal | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal | |
Shire Pharmaceuticals LLC
 Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| F2g Inc. | Director/Board Member President | ||
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Drugstore Chains | Founder Chairman | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| CIRCIO HOLDING ASA | Biotechnology | Director/Board Member Chairman | |
| INHIBIKASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Stockholm | College/University | Undergraduate Degree Undergraduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Doctorate Degree |
Statistics
International
| United States | 19 |
| Sweden | 9 |
| Switzerland | 8 |
| United Kingdom | 6 |
| France | 4 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 6 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 366 |
| Chairman | 108 |
| Corporate Officer/Principal | 106 |
| Independent Dir/Board Member | 76 |
| Founder | 47 |
Most connected contacts
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Philippe Pouletty | 51 |
| Ian Clark | 35 |
| Carl Erik Mathias Uhlén | 32 |
| Stig Anders Lindberg | 31 |
| Marc M. P. de Garidel | 31 |
| Patrick Volkert Vink | 30 |
| J. Kenneth Charles Knowles | 29 |
| Erich Hunziker | 28 |
| Sylvie Grégoire | 25 |
| Carol Brosgart | 25 |
| Olivier Jean Bohuon | 24 |
| Clive Meanwell | 21 |
| Jose F. Suarez | 19 |
| Simona Heidempergher | 16 |
- Stock Market
- Insiders
- Camilla Soenderby
- Company connections
